Part, Chapter, Paragraph
1 -, 1 | experts listed in Appendix 2; (iv) supervised by officers
2 -, 1 | description and analysis; (iv) Risk factors; (v) Control
3 I, 2. 1 | education and training; and (iv) increased savings available
4 II, 5. 4. 2 | HIS/HES/SPSN/RS Registries~IV Epidemiology of complications~ ~ ~
5 II, 5. 4. 2 | mellitus by 10 year age bands~2~IV Epidemiology of complications~ ~
6 II, 5. 5. 3 | Interleukin~IM~Intramuscularly~IV~Intravenously~IVIG~Intravenous
7 II, 5. 5. 3 | reach €9,200 per patient (HY IV).~ ~ ~Figure 5.5.3.6.3.
8 II, 5. 5. 3 | decrease of costs in HY stages IV and V has been reported,
9 II, 5. 7. 3 | USA (NHANES III and NHANES IV performed between 1988-1994
10 II, 5. 7. 3 | NHANES III) to 16.8% (NHANES IV) (Tonelli et al, 2006; Zoccali
11 II, 5. 8. 3(27)| FEV1 <50% predicted~Stage IV:~Very Severe FEV1/FVC <0.
12 II, 5. 9. 4 | timothy grass; (iii) cat; (iv) Cladosporium herbarium; (
13 II, 7. 5 | for injury prevention; (iv) to promote evidence-based
14 II, 8. 2. 1 | developmental period’. DSM IV (American Psychiatric Association’
15 II, 8. 2. 1 | Mental Disorders, Version IV, 1994) provides a similar
16 II, 8. 2. 1 | functioning”. Both ICD10 and DSM IV definitions note that deficits
17 II, 9. 2. 5 | outdoor and indoor air~· RPG IV: aim at chemical-free environments~
18 III, 10. 2. 1 | related infectious diseases; (iv) drug-related deaths and
19 III, 10. 4. 2 | active substances in Annex IV to the Regulation, submitted
20 IV | PART IV – PROTECTING AND PROMOTING
21 IV, 12. 6 | and health insurance; and (iv) industry with a particular
22 IV, 13. 7. 3 | Marie Curie’ actions); and (iv) developing research capacities
